Business Plan · Confidential
🔒
Park Medi World Business Plan
Network expansion roadmap, cluster-based growth strategy, acquisition pipeline, operational integration playbook, use of $300M pre-IPO proceeds, and competitive positioning. Authorized investors only.
Business Plan · Confidential
Park Medi World
Business Plan

Five-year expansion roadmap to 4,350 beds, cluster-based M&A strategy, operational integration playbook, technology rollout, use of $300M pre-IPO proceeds, and path to IPO. Confidential — authorized investors only.

Raise: $300M · 20% Equity · $1.5B Valuation
Route: Pre-IPO → IPO
Horizon: FY26–FY28
Strategic Targets
Beds by Mar-20284,350
New Bed Additions+1,350
Capex Focus67% tier 2/3 cities
State ExpansionHaryana · UP · Delhi
Target EBITDA Margin25–28%
IPO Post Pre-IPONear-term
01
Strategy
Three Pillars of Growth

The business plan is structured around three interlocking pillars executed in parallel over the FY26–FY28 horizon:

  • Expand the network — grow presence in neighbouring states adjacent to the existing Haryana-centric cluster, with ~67% of planned capex deployed in tier 2/3 cities where bed density is below the NHP benchmark.
  • Scale operations and efficiency — deploy iMARS robotics across more hospitals, add super-specialty services (kidney transplants approved at 5 hospitals), upgrade IT platforms, and drive cash-pay/insurance/international patient mix.
  • Talent acquisition and retention — training, leadership development, digital CME access, and structured career pathways across the 891-doctor/1,912-nurse team.
02
Bed Pipeline
From 3,000 to 4,350 Beds by March 2028
State30-Sep-2431-Mar-28AdditionSource
Haryana1,6002,350+750Panchkula, Rohtak greenfield; Ambala expansion
Rajasthan5505500Stable (Behror, Jaipur)
Punjab6506500Stable (Patiala, Mohali)
Delhi200400+200Febris Hospital acquisition (200 beds)
Uttar Pradesh400+400Gorakhpur O&M agreement
Total3,0004,350+1,350Organic + Inorganic
Expansion Initiatives
Panchkula (300 beds) and Rohtak (250 beds) — greenfield construction in existing Haryana cluster. Ambala (+450 beds) — capacity expansion at acquired Healing Touch facility. Gorakhpur (400 beds) — O&M agreement giving UP entry without upfront land/build capex. Febris Hospital, New Delhi (200 beds) — acquisition through the successful resolution applicant process, densifying Delhi cluster.
03
M&A Playbook
7 Hospitals Acquired · INR 5,205mn Cumulative

Park has acquired and integrated 7 hospitals for cumulative consideration of INR 5,205mn. Those acquired hospitals contributed ~41% of FY24 EBITDA (INR 3,103mn) — demonstrating that the capital deployed has approached payback within a single year of the full EBITDA run-rate of the acquired portfolio.

HospitalAcquiredBedsConsideration (INR mn)
Park Hospital, FaridabadDec-11150110
Park Hospital, KarnalApr-17150250
Healing Touch, AmbalaApr-20250600
Park Hospital, BehrorNov-20300400
Park Hospital, Palam ViharFeb-212251,075
Nidaan Hospital, SonipatJul-21225520
Grecian Hospital, MohaliMay-233502,250
Total1,6505,205
Organic Beds (H1 FY25)
1,100
45% of capacity
Acquired Beds (H1 FY25)
1,650
55% of capacity
Acquired Revenue Contribution
55%
FY24
Acquired EBITDA Contribution
41%
FY24 · Mohali in gestation
04
Operational Excellence
The Affordability-and-Margin Machine

Park runs the lowest-cost, highest-margin hospital chain among listed Indian peers. This is achieved through a deliberate operating model:

  • Asset ownership — 10 of 13 hospitals are owned outright (land, building, equipment), eliminating rent drag.
  • In-house full-time staffing — doctors, consultants, nurses, and allied staff on payroll (not revenue-share) wherever possible.
  • Shared resources across the cluster — doctors rotate between hospitals, procurement is centralised, and referrals stay within the network.
  • Standardised protocols — same clinical and operational playbook deployed at every acquired facility within 6–12 months.
  • High government-scheme mix — 89% of revenue from government and PSU panels, giving revenue predictability and working capital structure tailored to that realisation cycle (Trade Receivable Days ~151).
Gross Block per Bed
INR 3.2 mn
Lowest among listed peers
ARPOB H1 FY25
INR 25,674/day
Lowest among peers · by design
Occupancy H1 FY25
62%
Headroom for margin expansion
ALOS H1 FY25
6.66 days
Down from 7.07 in FY22
05
Technology
Super-Specialty & Advanced Equipment Rollout

Park has deployed iMARS advanced robotics systems at 3 hospitals for minimally invasive procedures and is expanding this across additional sites. 5 hospitals are approved for kidney transplant procedures, unlocking a high-value super-specialty revenue stream. The hospital network runs a broad fleet of modern equipment: Medical linear accelerator (external beam radiation); PET-CT scanners for oncology, surgical planning, radiation therapy; MRI, CT, ultrasound, digital X-ray; dialysis machines; biplane cath laboratory for pediatrics, electrophysiology, neuro-interventions; advanced laboratory analyzers across hematology, biochemistry, microbiology, molecular biology, and histopathology.

Parallel investments are being made in international-patient acquisition (new dedicated department), cash-pay and insurance panel teams, and HIS/IT platform upgrades to enable tighter cluster coordination.

06
Use of Pre-IPO Proceeds
Where the $300M Goes
AllocationEstimatedPurpose
Greenfield Builds (Panchkula + Rohtak)$65M550 new beds across two tier 2 markets
Ambala Expansion$45M+450 beds at existing acquired facility
Febris Hospital Acquisition (Delhi)$35M200 beds · densify Delhi cluster
Gorakhpur O&M Launch$20MWorking capital + equipment for 400-bed UP entry
Technology & Robotics Rollout$40MiMARS expansion, HIS upgrade, imaging capex
Working Capital · Acquired-Hospital Gestation$50M12–24 month ramp for new/acquired sites
Debt Reduction$30MBalance-sheet optimisation pre-IPO
General Corporate / Reserve$15MOpportunistic M&A / contingency
Total Pre-IPO Raise$300MFor 20% equity at $1.5B valuation
07
Risk Framework
Identified Risks & Mitigants
MEDIUM
Gestation period for Grecian Mohali (acquired May-23)
Mitigant: 12–24 month ramp is within the established post-acquisition playbook. FY24 EBITDA contribution from acquisitions at ~41% is pre-Mohali-maturity. Full EBITDA run-rate from Mohali expected from FY26.
MEDIUM
Government scheme payment cycles (89% revenue mix)
Mitigant: Working capital cycle is managed (151 days H1 FY25, improved from 168 in FY24). Mix diversification through cash-pay, insurance, and international-patient initiatives reduces concentration. Debt-to-equity down from 0.95 (FY22) to 0.62 (H1 FY25).
MEDIUM
Regulatory pricing controls on medical consumables and procedures
Mitigant: Low-ARPOB, high-volume model is structurally less sensitive to price caps than premium-ARPOB peers. Affordable-care positioning aligned with government policy direction.
HIGHER
Talent retention in competitive markets
Mitigant: 20+ year track record of promoter-led medical leadership (Dr. Ajit Gupta, Dr. Ankit Gupta). Dedicated training programs, leadership development, and digital CME access. Park's multi-hospital cluster model gives doctors career mobility within the network.
LOWER
IPO market timing
Mitigant: DRHP already filed with SEBI (March 28, 2025). BRLMs engaged: Nuvama, CLSA India, DAM Capital, Intensive Fiscal Services. Pre-IPO structure itself de-risks listing by providing near-term capital independent of public market timing.

Financial model & deep-dive KPIs

Detailed historicals, projections, balance sheet, working capital, and peer comp financials available under separate password.

Disclaimer · Confidential Business Plan
Strictly Confidential
This Business Plan is confidential and for the exclusive use of the authorised recipient. It contains forward-looking statements subject to risks and uncertainties; actual results may differ materially. Refer to the DRHP filed March 28, 2025 for the definitive disclosure set.

Park Medi World Limited · www.parkhospital.in